U.S. markets open in 4 hours 17 minutes
  • S&P Futures

    3,788.00
    +25.75 (+0.68%)
     
  • Dow Futures

    30,885.00
    +165.00 (+0.54%)
     
  • Nasdaq Futures

    12,927.50
    +125.25 (+0.98%)
     
  • Russell 2000 Futures

    2,146.90
    +26.10 (+1.23%)
     
  • Crude Oil

    52.54
    +0.18 (+0.34%)
     
  • Gold

    1,842.00
    +12.10 (+0.66%)
     
  • Silver

    25.39
    +0.52 (+2.11%)
     
  • EUR/USD

    1.2132
    +0.0048 (+0.40%)
     
  • 10-Yr Bond

    1.0970
    0.0000 (0.00%)
     
  • Vix

    22.97
    -0.28 (-1.20%)
     
  • GBP/USD

    1.3623
    +0.0036 (+0.27%)
     
  • USD/JPY

    103.9980
    +0.3110 (+0.30%)
     
  • BTC-USD

    37,157.06
    +715.33 (+1.96%)
     
  • CMC Crypto 200

    733.54
    -1.60 (-0.22%)
     
  • FTSE 100

    6,738.98
    +18.33 (+0.27%)
     
  • Nikkei 225

    28,633.46
    +391.25 (+1.39%)
     

Company News for Dec 10, 2020

Zacks Equity Research
·1 min read
  • Shares of United Natural Foods, Inc. UNFI plummeted 14.3% after the company reported first-quarter fiscal 2021 earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.73 per share.

  • Cardtronics plc’s CATM shares surged 31.9% after the company said that it has received a buyout offer from Apollo Global Management and Hudson Executive Capital.

  • Shares of FireEye, Inc. FEYE declined 13.1% after the company revealed that its tools used to test its customers were accessed by sophisticated hackers.

  • Eli Lilly and Company’s LLY shares jumped 5.8% after the company flagged positive data from the final-stage trial of its experimental type 2 diabetes drug.
     


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Eli Lilly and Company (LLY) : Free Stock Analysis Report
 
Cardtronics PLC (CATM) : Free Stock Analysis Report
 
United Natural Foods, Inc. (UNFI) : Free Stock Analysis Report
 
FireEye, Inc. (FEYE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research